Open-Label Rollover Study for Continuing Valbenazine Administration for the Treatment of Chorea Associated With Huntington Disease
Condition: Chorea, Huntington Intervention: Drug: Valbenazine Sponsors: Neurocrine Biosciences; Huntington Study Group Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials